Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Background: Apatinib is a powerful inhibitor of vascular endothelial growth factor receptor-2. This study was aimed to investigate whether apatinib could improve the efficacy of transarterial chemoembolization (TACE) in patients with advanced hepatocellular carcinoma (HCC). Methods: Between June 201...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Kan, Xuefeng, Liang, Bin, Zhou, Guofeng, Xiong, Bin, Pan, Feng, Ren, Yanqiao, Cao, Yanyan, Wang, Jihua, Yang, Fan, Zheng, Chuansheng
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7358575/
https://ncbi.nlm.nih.gov/pubmed/32733791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00970
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items